Efficacy and safety of delgocitinib in treating chronic hand eczema: A systematic review and meta-analysis of randomized controlled trials
Background: Chronic hand eczema (CHE) is a persistent inflammatory skin condition that is often difficult to manage and associated with substantial functional impairment and reduced quality of life. Delgocitinib, a topical pan-Janus kinase inhibitor, has emerged as a potential nonsteroidal therapeut...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2025-12-01
|
| Seri Bilgileri: | Proceedings of Singapore Healthcare |
| Online Erişim: | https://doi.org/10.1177/20101058251409425 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|